Growth through medical technology: Bosch and Randox invest heavily in the Vivalytic analysis platform

Novel Bosch BioMEMS technology helps save lives

  • New partnership for Vivalytic analysis platform: Bosch and Randox Laboratories Ltd. to invest 150 million euros in research, development, and distribution.
  • Strategic growth field: point-of-care molecular diagnostics expected to become a future market worth billions.
Subscribe to RSS - Bosch Randoz medicina